6/27/2025

Janusmed sex and gender

Janusmed sex and gender – Hydroxyzine

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
B B
B B

Hydroxyzine

Hydroxyzine

Class : B

Show all info

Print

Contact us

  1. Nationella riktlinjer för vård vid depression och ångestsyndrom 2021. Socialstyrelsen [www]. Socialstyrelsen. [updated 2021-04-01, cited 2021-05-14].

  2. Jalnapurkar I, Allen M, Pigott T. Sex Differences in Anxiety Disorders: A Review. J Psychiatr Depress Anxiety. 2018;4(1):2-9.

  3. Whang KA, Khanna R, Thomas J, Aguh C, Kwatra SG. Racial and Gender Differences in the Presentation of Pruritus. Medicines (Basel). 2019;6(4):.

  4. Schmid Y, Navarini A, Thomas ZM, Pfleiderer B, Krähenbühl S, Mueller SM. Sex differences in the pharmacology of itch therapies-a narrative review. Curr Opin Pharmacol. 2019;46:122-142.

  5. European Medicines Agency. PRAC recommends new measures to minimise known heart risks of hydroxyzine-containing medicines. European Medicines Agency [www]. European Medicines Agency. [updated 2015-02-13, cited 2015-08-11].

  6. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013-22.

  7. Herr GP, Conner JT, Schehl D, Dorey F. Comparison of i m diazepam and hydroxyzine as premedicants. Br J Anaesth. 1982;54:3-9.

  8. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2022 [cited 2023-03-02.]

  1. Nationella riktlinjer för vård vid depression och ångestsyndrom 2021. Socialstyrelsen [www]. Socialstyrelsen. [updated 2021-04-01, cited 2021-05-14].
  2. Jalnapurkar I, Allen M, Pigott T. Sex Differences in Anxiety Disorders: A Review. J Psychiatr Depress Anxiety. 2018;4(1):2-9.
  3. Whang KA, Khanna R, Thomas J, Aguh C, Kwatra SG. Racial and Gender Differences in the Presentation of Pruritus. Medicines (Basel). 2019;6(4):.
  4. Schmid Y, Navarini A, Thomas ZM, Pfleiderer B, Krähenbühl S, Mueller SM. Sex differences in the pharmacology of itch therapies-a narrative review. Curr Opin Pharmacol. 2019;46:122-142.
  5. European Medicines Agency. PRAC recommends new measures to minimise known heart risks of hydroxyzine-containing medicines. European Medicines Agency [www]. European Medicines Agency. [updated 2015-02-13, cited 2015-08-11].
  6. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013-22.
  7. Herr GP, Conner JT, Schehl D, Dorey F. Comparison of i m diazepam and hydroxyzine as premedicants. Br J Anaesth. 1982;54:3-9.
  8. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2022 [cited 2023-03-02.]